ProfileGDS5678 / 1443994_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 57% 56% 56% 54% 55% 56% 57% 55% 54% 55% 56% 55% 57% 55% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.4844957
GSM967853U87-EV human glioblastoma xenograft - Control 23.394756
GSM967854U87-EV human glioblastoma xenograft - Control 33.3984356
GSM967855U87-EV human glioblastoma xenograft - Control 43.2985554
GSM967856U87-EV human glioblastoma xenograft - Control 53.3128355
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.4908956
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.5349557
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.3754455
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.3282954
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.3722455
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.3883156
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.3201855
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.4467457
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.3858255